Skip to main content

Table 1 Baseline socio-demographic and clinical characteristics of the HAART patients (n = 792)

From: Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study

Variables Characteristics Median (IQR) n (%)
Weight Base line weight in K.G. 62 (58–70)  
Base line CD4 Baseline CD cell count 134 (113–180)  
Age Age in years 36 (28–48)  
1st month CD4 count change First month CD4 cell count change 15.9 (12–26)  
Sex Male   391(49.4%)
Female   401(50.6%)
Level of education. No educ.   160 (20.2%)
Primary   205 (25.9%)
Secondary   273(34.5%)
Tertiary   154 (19.4%)
Residence area Urban   468 (59.1%)
Rural   324 (40.1%)
Marital status Living with partner   355 (44.8%)
Living without Partner   437(55.2%)
Level of income Low income (<  500 ETB per month)   355 (44.8%)
Middle income (5001–999 ETB per month)   346 (43.7%)
High income (≥1000ETB per month)   91(11.5%)
WHO stages Stage I   101(12.8%)
Stage II   258 (32.6%)
Stage III   199 (25.1%)
Stage IV   234 (29.5%)
Disclosure level of disease to families Yes   575 (72.6%)
No   217 (27.4%)
Owner of cell phone/memory aids Yes   400 (50.5%)
No   392 (49.5%)
First month dose adherence Yes   392 (49.5%)
No   400 (50.5%)
First month food adherent Yes   385 (48.6%)
No   407 (51.4%)
First month time adherent Yes   350 (44.2%)
No   442 (55.8%)
First month adherence to HAART Yes   540 (68.18%)
No   252 (31.82%)
Social support Yes   500 (63%)
No   292 (37%)
\